InvestorsHub Logo
icon url

Just the facts maam

02/17/23 6:17 PM

#14166 RE: silvr_surfr #14165

Thank Silvr, it looks like Lawley will be the competition, globally. I figure ANIP's safety data will make it the drug of choice by prescribers and PBMs.

I guess we should find out some time this years.